Pediatric Rubella Workup

  • Author: Elias Ezike, MD; Chief Editor: Russell W Steele, MD   more...
 
Updated: Oct 3, 2011
 

Laboratory Studies

Postnatal rubella

A clinical diagnosis of rubella may be difficult to make because many exanthematic diseases may mimic rubella infection. In addition, as many as 50% of rubella infections may be subclinical; therefore, laboratory studies are important to confirm the diagnosis of acute rubella infection.

The laboratory diagnosis of rubella can be made either though serologic testing or by viral culture. The serologic diagnosis consists of demonstrating the presence of rubella-specific immunoglobulin M (IgM) antibody in a single serum sample or observation of a significant (>4-fold) rise in rubella-specific immunoglobulin G (IgG) antibody titer between the acute and convalescent serum specimens drawn 2-3 weeks apart.

False-positive rubella IgM test results have been reported in persons with other viral infections (eg, acute Epstein-Barr virus [EBV], infectious mononucleosis, cytomegalovirus [CMV] infection, parvovirus B19 infection) and in the presence of rheumatoid factor (RF).

To demonstrate a 4-fold rise in rubella-specific IgG antibody, a serum sample should be obtained as soon as possible during the acute phase of infection and tested for rubella-specific IgG antibody. An aliquot of this serum should be frozen and stored for repeat testing later. Then, a second serum specimen is collected at 2-3 weeks and tested in the same laboratory at the same time with the first serum sample. The levels of rubella-specific IgG are compared between the first and the second sample to show a significant rise in antibody titers.

Several techniques are available for serologic testing, including the following:

  • Enzyme-linked immunosorbent assay (ELISA)
  • Immunofluorescent assay (IFA)
  • Latex agglutination (LA) test
  • Hemagglutination inhibition (HI) test
  • Complement fixation (CF) test
  • Passive hemagglutination antibody (PHA) test
  • Hemolysis-in-gel test

Among all the serologic tests available, ELISA is the most widely used because it is relatively inexpensive, technically easy to perform, rapid, and very sensitive.

Rubella viral cultures are time consuming, expensive, not readily available, and used mainly for tracking the epidemiology of rubella virus during an outbreak.

The most commonly used method for isolation of rubella virus from clinical specimens, taken from an infected person, is the interference technique using African green monkey kidney (AGMK) cells and an enterovirus.

The specimen (urine or nasopharyngeal swab) is inoculated onto primary AGMK monolayers. After 9-12 days, the cultures are challenged with an enterovirus. If rubella is present, it interferes with the challenge virus and no cytopathic effect (CPE) is observed on the AGMK cells. HI, CF, and immunofluorescence techniques have also been used to detect rubella-specific antigens in tissue culture.

Congenital rubella

Congenital rubella in infants and children is diagnosed by viral isolation or by serologic testing. In contrast to postnatal infection, viral isolation is the preferred technique in congenital rubella syndrome because rubella serology may be difficult to interpret in view of transplacental passage of rubella-specific maternal IgG antibody. In addition, rubella-specific IgM antibody may not be detectable at the time of evaluation. Congenital rubella syndrome has also been diagnosed using placental biopsy, rubella antigen detection by monoclonal antibody, and polymerase chain reaction (PCR).

Specimens used for viral isolation in congenital rubella include nasopharyngeal swab, urine, cerebrospinal fluid, and buffy coat of the blood.

In some infants with congenital rubella syndrome, rubella virus can persist and can be isolated from the nasopharyngeal and urine cultures throughout the first year of life or later.

The same serologic testing methods (ELISA, IFA, LA, HI, CF) discussed for postnatal rubella can be used to detect specific antibodies in congenital infection.

Rubella-specific IgM antibody is actively produced by the fetus or neonate and may be detected in the cord blood or neonatal serum.

Congenital rubella syndrome should be strongly suspected in infants older than 3 months if rubella-specific IgG antibody levels are observed and do not decline at the rate expected from passive transfer of maternal antibody (ie, equivalent of a 2-fold decline in HI titer per mo) in a compatible clinical situation.

Patients with concomitant immunodeficiency, such as agammaglobulinemia or dysgammaglobulinemia, may have a false-negative serology result for rubella. Therefore, viral isolation is required to confirm the diagnosis in this group of patients.

Next

Imaging Studies

Postnatal rubella

Imaging studies are usually not performed in postnatal rubella.

Congenital rubella syndrome

Chest radiography is indicated for infants who develop respiratory distress or other respiratory symptoms to exclude rubella-related interstitial pneumonitis or pulmonary edema that may result from congestive heart failure in children with severe or complicated congenital heart anomalies.

Radiography of the long bones may reveal radiolucencies in the metaphyses of long bones.

Echocardiography is important for patients with congenital heart defects to help diagnose the type of heart anomaly and evaluate the severity of the heart defect so that appropriate surgical plans can be made.

CT scanning of the head may reveal intracranial calcifications and enlargement of the ventricles.

MRI of the head may reveal cortical atrophy and white matter changes in patients with late-onset progressive panencephalitis.

Previous
Next

Other Tests

CBC count may reveal leukopenia and thrombocytopenia. It is used to monitor the course of thrombocytopenia.

Liver function tests, such as total and direct bilirubin, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and gamma-glutamyl transpeptidase levels may reveal hepatic injury due to disseminated rubella infection, especially in neonates.

Previous
Next

Procedures

Lumbar puncture is indicated to evaluate for possible causes in children who develop signs and symptoms of meningoencephalitis, such as full anterior fontanelle, irritability, hypotonia, seizures, lethargy, head retraction, and arching of the back.

In patients with rubella-related meningoencephalitis, CSF examination usually reveals normal glucose levels, normal or slightly elevated protein levels, and mild pleocytosis (20-100 WBC/mcL) with lymphocyte predominance.

Previous
Next

Histologic Findings

Postnatal rubella

Histologically cutaneous lesions are nonspecific and demonstrate only a mild, superficial, perivascular, lymphocytic infiltrate.

Congential rubella

The gross neuropathologic features that present during autopsy of babies who are stillborn include microcephaly and various other malformations (ie, polymicrogyria, nonhemorrhagic subependymal germinal matrix cysts). Histologically, chronic inflammatory cells are found in the meninges and surrounding the intraparenchymal blood vessels. The vessel walls also show foci of subintimal fibrosis and mineralization.

Previous
 
 
Contributor Information and Disclosures
Author

Elias Ezike, MD  Consulting Staff, Beaumont Pediatric Center, PLLC

Elias Ezike, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Coauthor(s)

Jocelyn Y Ang, MD  Assistant Professor, Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Michigan and Wayne State University

Jocelyn Y Ang, MD is a member of the following medical societies: American Academy of Pediatrics, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Leonard R Krilov, MD  Chief of Pediatric Infectious Diseases and International Adoption, Vice Chair, Department of Pediatrics, Professor of Pediatrics, Winthrop University Hospital

Leonard R Krilov, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research

Disclosure: Medimmune Grant/research funds Cliinical trials; Medimmune Honoraria Speaking and teaching; Medimmune Consulting fee Consulting

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Leslie L Barton, MD  Professor Emerita of Pediatrics, University of Arizona College of Medicine

Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: Novartis Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References
  1. Pandolfi E, Chiaradia G, Moncada M, Rava L, Tozzi AE. Prevention of congenital rubella and congenital varicella in Europe. Euro Surveill. Mar 5 2009;14(9):16-20. [Medline].

  2. CDC. Summary of notifiable diseases, United States, 1996. MMWR Morb Mortal Wkly Rep. Oct 31 1997;45(53):1-87. [Medline].

  3. CDC. Reported Cases of Notifiable Diseases-United States, 1972-2003. MMWR. Apr 2005;52(54):73-78.

  4. CDC. Provisional cases of infrequently reported notifiable diseases. MMWR. January 9, 2009;57(53):1420-1431.

  5. CDC. Provisional Cases of Infrequently Reported Notifiable Diseases-United States. MMWR. Jan 2009;55(19):538.

  6. Institute for Clinical Systems Improvement. Immunizations. Bloomington, MN: ICSI; 2008.

  7. Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. Jul 2010;126(1):e1-8. [Medline].

  8. Hviid A. Measles-mumps-rubella-varicella combination vaccine increases risk of febrile seizure. J Pediatr. Jan 2011;158(1):170. [Medline]. [Full Text].

  9. [Guideline] Marin M, Broder KR, Temte JL, Snider DE, Seward JF. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. May 7 2010;59:1-12. [Medline]. [Full Text].

  10. American Academy of Pediatrics; Committee on Infectious Diseases. Policy Statement--Prevention of Varicella: Update of Recommendations for Use of Quadrivalent and Monovalent Varicella Vaccines in Children. Pediatrics. Aug 28 2011;[Medline].

  11. Dontigny L, Arsenault MY, Martel MJ, et al. Rubella in pregnancy. J Obstet Gynaecol Can. Feb 2008;30(2):152-68. [Medline].

  12. American Academy of Pediatrics. 2003 Red Book: Report of the Committee on Infectious Diseases. 26th ed. American Academy of Pediatrics; 2003.

  13. Bale JF Jr, Murph JR. Congenital infections and the nervous system. Pediatr Clin North Am. Aug 1992;39(4):669-90. [Medline].

  14. Bialecki C, Feder HM Jr, Grant-Kels JM. The six classic childhood exanthems: a review and update. J Am Acad Dermatol. Nov 1989;21(5 Pt 1):891-903. [Medline].

  15. Bullens D, Smets K, Vanhaesebrouck P. Congenital rubella syndrome after maternal reinfection. Clin Pediatr (Phila). Feb 2000;39(2):113-6. [Medline].

  16. CDC. Elimination of rubella and congenital rubella syndrome--United States, 1969-2004. MMWR Morb Mortal Wkly Rep. Mar 25 2005;54(11):279-82. [Medline].

  17. CDC. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004. MMWR Morb Mortal Wkly Rep. Feb 25 2005;54(7):175-8. [Medline].

  18. CDC. Quarterly immunization table. MMWR. July 1997.

  19. CDC. Reportable diseases (1998 provisional data). MMWR. 2000;48:1183-89.

  20. CDC. Rubella among Hispanic adults--Kansas, 1998, and Nebraska, 1999. MMWR Morb Mortal Wkly Rep. Mar 24 2000;49(11):225-8. [Medline].

  21. CDC. Rubella outbreak--Westchester County, New York, 1997-1998. MMWR Morb Mortal Wkly Rep. Jul 9 1999;48(26):560-3. [Medline].

  22. Cherry JD. Contemporary infectious exanthems. Clin Infect Dis. February 1993;16(2):199-205. [Medline].

  23. Cherry JD. Rubella virus. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. Vol 2. 4th ed. WB Saunders Co; 1998:1922-49.

  24. Cherry JD. Viral exanthems. Curr Probl Pediatr. Apr 1983;13(6):1-44. [Medline].

  25. Editorial. TORCH syndrome and TORCH screening. Lancet. Jun 30 1990;335(8705):1559-61. [Medline].

  26. Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine. August-September 1998;16(14-15):1456-1463. [Medline].

  27. Freij BJ, South MA, Sever JL. Maternal rubella and the congenital rubella syndrome. Clin Perinatol. Jun 1988;15(2):247-57. [Medline].

  28. Giles CL. Uveitis in childhood - Part III Posterior. Ann Ophthalmol. January 1989;21(1):23-28. [Medline].

  29. Gold E. Almost extinct diseases: measles, mumps, rubella, and pertussis. Pediatr Rev. Apr 1996;17(4):120-7. [Medline].

  30. Horstmann DM. Rubella. In: Evans AS, ed. Viral Infections of Humans, Epidemiology and Control. 3rd ed. Premium Medical Book Co; 1991:617-30.

  31. Kimberlin DW. Rubella immunization. Pediatr Ann. Jun 1997;26(6):366-70. [Medline].

  32. Lindegren ML, Fehrs LJ, Hadler SC, Hinman AR. Update: rubella and congenital rubella syndrome, 1980-1990. Epidemiol Rev. 1991;13:341-8. [Medline].

  33. Lutwick LI. Postexposure prophylaxis. Infect Dis Clin North Am. Dec 1996;10(4):899-915. [Medline].

  34. Maldonado YA. Rubella virus. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. Churchill Livingstone; 1997:1228-37.

  35. Miller E. Rubella reinfection. Arch Dis Child. Aug 1990;65(8):820-1. [Medline].

  36. Morgan-Capner P. Diagnosing rubella. BMJ. Aug 5 1989;299(6695):338-9. [Medline].

  37. Munoz FM, Englund JA. A step ahead. Infant protection through maternal immunization. Pediatr Clin North Am. Apr 2000;47(2):449-63. [Medline].

  38. Parkman PD. Making vaccination policy: the experience with rubella. Clin Infect Dis. Jun 1999;28 Suppl 2:S140-6. [Medline].

  39. Powell S, Schochet SS Jr. Selected pediatric viral infections. Semin Pediatr Neurol. Sep 1995;2(3):211-9. [Medline].

  40. Reef S, Zimmerman-Swain L, Coronado V. Rubella. In: VPD Surveillance Manual. 1999:11.

  41. Robinson J, Lemay M, Vaudry WL. Congenital rubella after anticipated maternal immunity: two cases and a review of the literature. Pediatr Infect Dis J. Sep 1994;13(9):812-5. [Medline].

  42. Rosa C. Rubella and rubeola. Semin Perinatol. Aug 1998;22(4):318-22. [Medline].

  43. Watson JC, Hadler SC, Dykewicz CA, et al. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. May 22 1998;47(RR-8):1-57. [Medline].

  44. Webster WS. Teratogen update: congenital rubella. Teratology. Jul 1998;58(1):13-23. [Medline].

  45. Weiter JJ, Roh S. Viral infections of the choroid and retina. Infect Dis Clin North Am. Dec 1992;6(4):875-91. [Medline].

  46. Wharton M, Cochi SL, Williams WW. Measles, mumps, and rubella vaccines. Infect Dis Clin North Am. Mar 1990;4(1):47-73. [Medline].

Previous
Next
 
Number of rubella cases per year.
Number of congenital rubella syndrome cases per year.
Deaths from rubella per year.
Image in a 4-year-old girl with a 4-day history of low-grade fever, symptoms of an upper respiratory tract infection, and rash. Courtesy of Pamela L. Dyne, MD.
Table 1. Reported Cases of Rubella, Deaths From Rubella, and Number of Cases of Congenital Rubella Syndrome in the United States From 1969-2007[2, 3, 4, 5]
YearNumber of CasesNumber of DeathsCases of Congenital Rubella Syndrome
196957,6862931
197056,5523177
197145,0862068
197225,5071442
197327,8041635
197411,9171545
197516,6522130
197612,4911230
197720,3951723
197818,2691030
197911,795162
19803,904150
19812,077519
19822,32547
1983970322
198475215
198563010
198655115
198730605
198822516
198939643
19901,125811
19911,401147
1992160111
199319205
199422707
199512816
199623804
199718105
199836407
199926709
200017609
20012323
200218N/A1
20037N/A1
200410N/A0
200511N/A1
200611N/A1
200712N/A0
Table 2. Clinicopathologic Abnormalities in Congenital Rubella
Abnormality Common/UncommonEarly/DelayedComment
General
Intrauterine growth retardationCommonEarly...
PrematurityUncommonEarly...
StillbirthUncommonEarly...
AbortionUncommonEarly...
Cardiovascular system
Patent ductus arteriosusCommonEarlyMay occur with pulmonary artery stenosis
Pulmonary artery stenosisCommonEarlyCaused by intimal proliferation
Coarctation of the aortaUncommonEarly...
MyocarditisUncommonEarly...
Ventricular septal defectUncommonEarly...
Atrial septal defectUncommonEarly...
Eye
CataractCommonEarlyUnilateral or bilateral
RetinopathyCommonEarlySalt-and-pepper appearance; visual acuity unaffected; frequently unilateral
Cloudy corneaUncommonEarlySpontaneous resolution
GlaucomaUncommonEarly/DelayedMay be bilateral
MicrophthalmiaCommonEarlyCommon in patients with unilateral cataract
Subretinal neovascularizationUncommonDelayedRetinopathy with macular scarring and loss of vision
Ear
Hearing lossCommonEarly/DelayedUsually bilateral; mostly sensorineural; may be central in origin; rare when maternal rubella occurs >4 months' gestation; sometimes progressive
CNS
MeningoencephalitisUncommonEarlyTransient
MicrocephalyUncommonEarlyMay be associated with normal intelligence
Intracranial calcificationsUncommonEarly...
Encephalographic abnormalitiesCommonEarlyUsually disappear by age 1 y
Mental retardationCommonDelayed...
Behavioral disordersCommonDelayedFrequently related to deafness
AutismUncommonDelayed...
Chronic progressive panencephalitisUncommonDelayedManifest in second decade of life
HypotoniaUncommonEarlyTransitory defect
Speech defectsCommonDelayedUncommon in absence of hearing loss
Skin
Blueberry muffin spotsUncommonEarlyRepresents dermal erythropoiesis
Chronic rubelliform rashUncommonEarlyUsually generalized; lasts several weeks
Dermatoglyphic abnormalitiesCommonEarly...
Lungs
Interstitial pneumoniaUncommonDelayedGeneralized; probably immunologically mediated
Liver
HepatosplenomegalyCommonEarlyTransient
JaundiceUncommonEarlyUsually appears in the first day of life
HepatitisUncommonEarlyMay not be associated with jaundice
Blood
ThrombocytopeniaCommonEarlyTransient; no response to steroid therapy
AnemiaUncommonEarlyTransient
Hemolytic anemiaUncommonEarlyTransient
Altered blood group expressionUncommonEarly...
Immune system
HypogammaglobulinemiaUncommonDelayedTransient
LymphadenopathyUncommonEarlyTransient
Thymic hypoplasiaUncommonEarlyFatal
Bone
Radiographic lucenciesCommonEarlyTransient; most common in distal femur and proximal tibia
Large anterior fontanelUncommonEarly...
MicrognathiaUncommonEarly...
Endocrine glands
Diabetes mellitusCommonDelayedUsually becomes apparent in second or third decade of life
Thyroid diseaseUncommonDelayedHypothyroidism, hyperthyroidism, and thyroiditis
Growth hormone deficiencyUncommonDelayed...
Genitourinary system
CryptorchidismUncommonEarly...
Polycystic kidneyUncommonEarly...
Table 3. Age-Specific CD4+ T-lymphocyte Count and Percentage of Total Lymphocytes as a Criteria for Severe Immunosuppression in Persons with HIV
Age Range
< 12 mo1-5 y6-12 y≥13 y
Total CD4+ T-lymphocytes< 750/mcl< 500/mcl< 200/mcl< 200/mcl
CD4+ T-lymphocytes (as % of total lymphocytes)< 15%< 15%< 15%< 14%
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.